SpaceX Stock Is Down 22% From Its Peak. History Says This Is How Low It Will Go -- and What Comes Next.

SpaceX shares are down ~22% from their IPO peak and the article warns the stock could decline nearly another ~30% based on past large IPO patterns. While Nasdaq-100 inclusion (after the July 6, 2026 close) could provide a temporary bid via index-tracking funds, insider selling post-lockup is flagged as a potential overhang (about 20% of eligible insider shares starting after the mid-August Q2 update, with additional staggered sales up to ~28% after Q3). The piece argues valuation remains stretched versus last year’s ~$18.7B revenue and suggests risk remains elevated for dip-buyers.

Analysis

Near term, this is a flow-driven name, not a fundamentals-driven one. The only real bullish catalyst in the next few sessions is mechanical index demand, which can lift price temporarily but rarely changes the medium-term clearing level once passive buying is done. That matters because a newly public, tightly held stock with heavy narrative ownership is highly sensitive to incremental supply; a few waves of insider selling can overwhelm enthusiasm much faster than buyers expect.

The bigger issue is float expansion versus growth durability. A valuation this rich needs either accelerating revenue or persistent scarcity to avoid multiple compression; if neither shows up into the next two reporting windows, the market will start pricing the company like a normal high-growth asset instead of a scarcity asset. That sets up a classic post-IPO unwind: first the index inclusion pop, then the lockup overhang, then a more structural de-rating over 1-3 quarters.

The contrarian miss is that the main risk is not "bad news" but ordinary news. If insider sales are orderly and disclosure is light, the stock can stay elevated longer than skeptics expect; the cleaner short trigger is not the IPO itself, but evidence that secondary supply is arriving faster than passive demand. In the broader tape, this can also sap appetite for other momentum-heavy, story-driven names like TSLA and RIVN as capital rotates away from high-beta retail favorites toward earnings-backed compounders.

Key Decisions for Investors

• If SPCX is still trading on index-inclusion momentum, wait for that flow to pass before initiating bearish exposure; preferred entry is 1-2 weeks after the passive rebalance rather than into it.
• Short SPCX on the first confirmed insider-sale window after the next earnings update, or buy 1-3 month put spreads if borrow is tight; thesis is multiple compression from float expansion, not business collapse.
• Pair trade: short SPCX vs long NVDA or META as quality-growth hedges; use this when you want to express dislike for speculative IPO valuation without taking outright market risk.
• Watch for falsifiers: a sustained hold above the post-IPO high through the first two lockup windows, or a second-quarter update that shows accelerating revenue and no insider supply, would invalidate the short thesis.